{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:02:30Z","timestamp":1790791350538,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.hlc.2024.03.008","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T12:56:48Z","timestamp":1712840208000},"page":"704-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8520-152X","authenticated-orcid":false,"given":"Giacomo","family":"Tini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-9609","authenticated-orcid":false,"given":"Matteo","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allegra","family":"Battistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Canepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-7287","authenticated-orcid":false,"given":"Pietro","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2024.03.008_bib1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11897-019-00451-0","article-title":"Heart failure with mid-range ejection fraction","volume":"17","author":"Srivastava","year":"2020","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hlc.2024.03.008_bib3","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2024.03.008_bib4","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1234","article-title":"Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis","volume":"20","author":"Komajda","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hlc.2024.03.008_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/joim.13487","article-title":"Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction","volume":"292","author":"De Marzo","year":"2022","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.hlc.2024.03.008_bib6","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","article-title":"Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study","volume":"38","author":"Ouwerkerk","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.008_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/eurheartj\/ehac710","article-title":"Cancer is a comorbidity of heart failure","volume":"44","author":"Ameri","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.008_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.008_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13273","article-title":"Cancer in chronic heart failure patients in the GISSI-HF trial","volume":"50","author":"Ameri","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.hlc.2024.03.008_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ejhf.1165","article-title":"Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge","volume":"20","author":"Ameri","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hlc.2024.03.008_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2019.01.082","article-title":"Arterial hypertension in cancer: the elephant in the room","volume":"281","author":"Tini","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2024.03.008_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000495576","article-title":"Ivabradine in cancer treatment-related left ventricular dysfunction","volume":"63","author":"Sarocchi","year":"2018","journal-title":"Chemotherapy"},{"key":"10.1016\/j.hlc.2024.03.008_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2019.10.008","article-title":"Comorbidities in chronic heart failure: an update from Italian Society of Cardiology (SIC) Working Group on Heart Failure","volume":"71","author":"Correale","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hlc.2024.03.008_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12955-020-01566-y","article-title":"Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review","volume":"18","author":"Com\u00edn-Colet","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.hlc.2024.03.008_bib16","article-title":"Cancer mortality in trials of heart failure with reduced ejection fraction: a systematic review and meta-analysis","volume":"9","author":"Tini","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hlc.2024.03.008_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.654728","article-title":"Diversity of cardiologic issues in a contemporary cohort of women with breast cancer","volume":"8","author":"Tini","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hlc.2024.03.008_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jchf.2020.04.019","article-title":"Care gaps in adherence to heart failure guidelines: clinical inertia or physiological limitations?","volume":"8","author":"Jarjour","year":"2020","journal-title":"JACC Heart Fail"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T06:20:20Z","timestamp":1717654820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950624001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1443950624001690"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2024.03.008","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2024.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}